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Abstract  
Background: Children with Down syndrome (DS) are vulnerable to obstructive sleep apnea 
(OSA) due to their unique craniofacial anatomy and hypotonia. Understanding the predictors 
of OSA in DS may inform targeted screening.  
Methods: 202 children with DS aged six months to sixth birthday (110 boys) were recruited 
from three UK children’s hospitals. Clinical assessment included height, weight and tonsillar 
size. Parents set up cardiorespiratory polygraphy at home or chose laboratory studies. Studies 
with less than four hours of interpretable data were repeated where possible. AASM 2012 
scoring criteria were used to derive an obstructive apnea/hypopnea index (OAHI). Predictors 
of moderate to severe OSA were examined. 
Results: 188/202 (93%) participants were successfully studied. Of these, 169 studies were 
completed at home and 19 in a sleep laboratory. Moderate –severe OSA, defined by an 
OAHI>5/hour, was found in 14%; and mild-moderate OSA (OAHI > 1 <5/hr) in 59% of 
children. Male gender and habitual snoring predicted OSA but did not have independent 
predictive power in the presence of the other factors. Age in months, BMI centile and 
tonsillar size did not predict OSA.  
Conclusions: Moderate to severe OSA is common in very young children with DS. 
Examination of tonsillar size did not predict OSA severity. Population based screening for 
OSA is recommended in these children and domiciliary cardiorespiratory polygraphy offers 
an acceptable screening approach. Further research is needed to understand the natural 
history, associated morbidity, optimal screening methodology and treatment modality for 
OSA in these children.  
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1. Background 
Down syndrome (DS) is the leading genetic cause of childhood intellectual disability 
worldwide affecting between 1 in 650-1000 live births1. Improved medical care means that 
children born this century are expected to live to middle age and beyond2. Increased life-
expectancy brings a welcome focus on quality of life.  
An extensive literature in typically developing (TD) children indicates that untreated OSA is 
associated with reduced quality of life3, increased health care utilization4, impaired attention5, 
learning6 and school performance7. There is every reason to assume the same would apply to 
children with DS. Indeed, a recent study of 38 children with DS identified an association 
between OSA, reduced cognitive flexibility and lower Verbal IQ8. Indeed, it is arguable that 
children with DS may be at higher risk of cognitive impairment than TD children, as they 
have limited cognitive reserve to compensate for OSA-induced neural insult. Furthermore, 
untreated OSA could be a risk factor for later life Alzheimer’s disease which affects 30% of 
adults with DS aged > 50 years9.  Thus, timely recognition and treatment of OSA in these 
children is an important goal for optimal cognitive functioning and quality of life. Guidelines 
for screening for OSA in these children have been published in the UK10  and US11. While 
these differ in their detail, both emphasise objective assessment of OSA with sleep studies 
before the age of 5 years and scheduled symptom enquiry in older children.   
Children with DS have multiple risk factors for OSA. Hypotonia, obesity and craniofacial 
anatomy (small midface and macroglossia) all contribute to upper airway collapse in sleep. 
This is further exacerbated in the pre-school years by growth of the adenotonsillar tissue12. 
Despite the evident risks of OSA in these children, over the past 25 years only eleven 
studies13,14,15,16,17,18,19,20,21,22,23 have reported the prevalence and correlates of OSA in a total of 
489 children. Reported prevalence rates vary significantly, from 0 to100%, reflecting the use 
of different, and often non-standard, scoring criteria for respiratory events, lack of agreement 
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as to what constitutes clinically relevant OSA and, in most, small sample size and/or wide 
age ranges.  
Seven studies reported correlates of OSA and findings are contradictory. In the two largest 
studies to date, de Miguel-Diez and colleagues17 reported on 108 children aged 1-18 years 
and Maris and colleagues on 122 children aged 1-10.5 years. Both observed an inverse 
relationship between OSA and age. This was supported by Dyken15 et al in a study of 19 
children aged 3-19 years, while conversely Ng et al reported the converse, namely a positive 
relationship between age and OSA in 22 children18. While de Miguel-Diez reported an 
association between OSA and male sex this was not supported by any other study. BMI 
would be predicted to be associated with OSA, and while two studies did report a positive 
associationError! Bookmark not defined., 18, five found none 13, 20, 21,22.  Both of the largest 
studies,17, 22 together reporting on 230 children, reported no association with tonsillar 
hyperplasia and one found no association with congenital heart disease17. 
Thus while published guidelines recommend routine OSA screening in young children, there 
is a lack of reliable data on population prevalence in this group. We aimed to recruit a large 
cohort of young children with DS to determine the prevalence and predictors of OSA and to 
generate a research cohort for long term follow-up. 
2. Methods 
 
2.1 Setting: This study was conducted in three children’s hospitals in the UK: Sheffield 
Children’s Hospital in the North of England, Evelina London Children’s Hospital, and 
Southampton Children’s Hospital in the South of England.  
2.2 Inclusion and exclusion criteria: Children were eligible for inclusion if they had a 
confirmed diagnosis of DS, were aged six months to sixth birthday and the family were 
prepared to travel to a recruiting centre. Exclusion criteria included: children screened for 
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OSA by cardiorespiratory study in the preceding 3 months; those receiving home oxygen 
therapy or non-invasive ventilation.  
2.3 Recruitment: Children were recruited between July 2013 and January 2015 by multiple 
routes: firstly by local neurodevelopmental paediatricians who either approached families 
directly, or indirectly through posters in child developmental centres, secondly through 
specialist paediatricians within the Children’s hospitals (cardiology, respiratory and 
neurology lists) and finally through advertising to local support groups, the UK Down 
Syndrome Association website and through word of mouth between parents.  
2.4 Ethics committee approval: The study was approved by the UK National Research ethics 
committee (reference number: 13/SC/0106) and was adopted by the National Institute of 
Health Research portfolio (ID: 14250). Parents provided written consent on behalf of their 
child.  
2.5 Measures:  
2.5.1. Demographic and medical history: Parents completed a questionnaire detailing 
educational level of the primary carer and their child’s relevant medical history including 
gestation at birth, history of adenoidectomy and/or tonsillectomy, rhinitis, asthma and 
congenital cardiac disease. Current snoring status was recorded based on response to the 
question: ‘How often does your child snore when they do NOT have a cold?’ with response 
options ‘Never, rarely, occasionally, almost always, always, unknown’.  
2.5.2 Clinical examination: Children were weighed and measured (length or height as 
appropriate to age) and DS-specific body mass index was computed from customized growth 
charts for children aged 2 years and over (Harlow publishing, UK). Where cooperation could 
be achieved, examination of the oropharynx was undertaken to grade tonsillar size using the 
Brodsky classification.  
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2.5.3 Domiciliary cardiorespiratory polygraphy (PG): OSA was assessed using the 
SOMNOtouch device (Somnomedics, Germany) comprising: chest and abdominal respiratory 
inductance plethysmography (RIP); pulse oximetry (Nonin) yielding oxyhemoglobin 
saturation (SpO2), plethysmography and pulse signals; nasal pressure flow with integral snore 
sensor; body position sensor; and actigraphy. The lightweight (50g) headbox allowed the 
device to be body-worn in all participants. Following pilot testing in healthy volunteer 
children, the equipment was customized for the purpose of the study with both shortened 
nasal prongs and connecting leads between the chest and abdominal RIP bands. This 
minimised risk of accidental disconnection of equipment or entanglement.  
2.5.4: Location of study and procedure: Children with DS are known to have restless sleep 
and compliance with sleep study sensors can be challenging. Parents were encouraged to 
attempt domiciliary PG studies to improve the child’s chance of achieving the best quality 
sleep. However, where parents expressed a preference, or if home studies failed, children 
were studied, using identical equipment, in an attended sleep laboratory environment. For 
domiciliary studies parents were trained in equipment set up and use, and RIP bands were 
measured to fit the child. Step by step written instructions, supplemented by photographic 
images of equipment set-up, were provided, along with a telephone contact number, in case 
of difficulties. Domiciliary studies were performed the night after parent training and devices 
were returned the next day by courier.  
2.6 Quality standards and scoring of sleep studies: A detailed standard operating procedure 
was generated. Studies were scored by an experienced technologist (RK), blinded to the 
clinical status of the child, using Domino Light software (Somnomedics, Germany). Every 
10th study acquired was re-scored by a second experienced technologist (JG) who was blind 
to the original scoring. Similarly, the original scorer was not aware of which study was to be 
re-scored. Sleep and wake were systematically estimated for each 30 second epoch using a 
Page | 8 
 
combination of a parental sleep log to interpret sleep onset and offset, and the in-device 
actigraphy. Artefact was marked for RIP, oximetry and nasal flow signals independently. To 
comply with AASM scoring criteria, where 2 or more signals were poor quality, global 
artefact was marked and data excluded. Studies with less than 4 hours of interpretable data24 
were rejected and parents were given the option of repeating the study at home or in the sleep 
laboratory. Respiratory events were scored according to standard pediatric scoring criteria for 
adapted sensors25. Specifically, obstructive apnea (OA) was scored when nasal pressure 
signal decreased to >90% amplitude of pre-event baseline for at least two breaths with 
ongoing inspiratory effort, and hypopnea where signal amplitude decreased by > 30% 
accompanied by a minimum of 3% oxyhemoglobin desaturation with ongoing inspiratory 
effort. Where nasal flow signal was lost, assuming that good quality RIP and oximetry signals 
were present, an ‘undefined apnea’ was scored, where RIP sum indicated paradoxical 
breathing in the presence of a minimum 3% oxyhemoglobin desaturation for at least 2 
breaths. Respiratory events were scored as a mixed apnea when OA criteria were met for at 
least the duration of 2 breaths during baseline breathing, associated with absent respiratory 
effort during one portion of the event and the presence of inspiratory effort in another portion, 
regardless of which portion came first. Central apnea (CA) was scored where inspiratory 
effort was absent for at least the duration of two breaths and was associated with ≥ 3% 
oxygen desaturation. In the absence of oxygen desaturation CA was also scored in children > 
12 months of age where inspiratory effort was absent for 20 seconds or longer and < 12 
months of age where the event lasted at least the duration of two breaths and was associated 
with a decrease in heart rate to < 50 beats per minute for at least 5 seconds or < 60 beats per 
minute for 15 seconds. Mean, minimum and 3% oxyhemoglobin desaturation index were 
automatically computed for total estimated sleep time. Total sleep time in minutes with high 
quality flow signal present was computed. The obstructive apnea/hypopnea index (OAHI) 
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was calculated by summing the obstructive apnea, hypopnea, mixed and undefined apnea 
indices.  
2.7 Statistical analysis: Data were entered into SPSS v 22 (IBM). Prior to analysis all data 
were inspected for normality. Differences between centres were examined using ANOVA, 
Kruskal-Wallis or chi-squared statistics depending on the type of variable. Two group 
comparison used two-sample t-tests, Mann-Whitney U or chi-squared tests as appropriate. 
The distribution of OAHI, log transformed for ease of presentation, is displayed using a 
dotplot. Prevalence of OSA defined by OAHI falling above previously suggested cut-point is 
expressed as a percentage with 95% confidence intervals (CI) calculated using CIA26. 
Reliability coefficients were produced in SPSS with 95% CIs to assess inter-rater reliability. 
Logistic regression with dependent variable (OAHI 5) was carried out for selected 
predictors of OSA on their own and in the presence of other predictors to assess independent 
predictive power. Odds ratios are presented with 95% CIs and tested for significance using 
likelihood ratio tests. 
3. Results  
3.1 Recruitment (figure 1) 
A total of 277 families were contacted by the recruitment sites and provided with information 
about the study. The multi-method recruitment approach was successful with 48% identified 
by their neurodevelopmental paediatrician, 21% by a tertiary specialist, 21% via websites and 
social media and 8% via personal recommendation from another participating parent. Data on 
method of identification of potential participants was missing for 8 cases. Recruitment rates 
were highest for eligible families referred by personal recommendation (90%); followed by 
neurodevelopmental paediatrician (79%); websites (66%) and tertiary paediatrician (61%).  
Of the 277 children identified, 266 (96%) met the eligibility criteria. Failure to meet the 
inclusion criteria included age (n=9) and use of home oxygen or non-invasive ventilation 
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therapy (n=2). Of the 266 remaining eligible children, families of 64 children (24%) decided 
not to participate; 19 did not give a reason (often failing to make further contact having 
received the study information); 10 cited factors relating to the child’s health, for example, 
planned surgery or recent ill health; 32 cited family related factors, for example, distance to 
travel to the research center or demands of the study; 1 family reported a previous negative 
experience of a sleep study and 2 families gave other reasons. There were no differences in 
age or gender between the 202 eligible children who were successfully recruited to the study 
and the eligible children where families chose to not take part (median age 2.8 years, versus 
median age 3.0 years, (range in both cases 0.5-5.9 years), P=0.54) and 110 (54%) versus 37 
(60%) boys respectively, P=0.67. Age was missing for 6 eligible children who were not 
recruited.  
3.2 Demographic and clinical data 
Demographic and clinical data are presented in table 1 for the 202 children recruited, both by 
recruitment site, and as a total across the entire study.  There were no differences between the 
sites in age or gender profiles, gestation at birth of participants, nor in educational level of the 
primary carer. Almost one third of participants always, or almost always, snored in the 
absence of a cold. Of the 32 children who had a history of adenoidectomy and/or 
tonsillectomy; 4 had tonsillectomy alone and 3 had adenoidectomy alone. Mean age at 
surgery was 48 months (range 5-68 months). Children with a history of upper airway surgery 
were significantly older than those who had not had surgery (median age 53.0 months, range  
31-71 months, versus 29.0 months, range 6-71 months; P<0.0001) but there were similar 
proportions who always or almost always snored in the absence of a cold (12/32 v 51/163, 
P=0.358). A history of rhinitis (n=46) and wheeze (n=96) was commonly reported. There 
were differences between sites with respect to children reported to wheeze (P=0.000) with a 
higher percentage at the Southampton site (68%) compared to London (40%) or Sheffield 
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(27%), although prophylactic inhaler use was similar across sites. There were also differences 
with respect to cigarette smoking in the home. Predictably, more of the children exposed to 
cigarette smoke were reported to wheeze compared to children who were not exposed (16/21, 
76% versus 80/180, 44%, P=0.006). More children in Southampton were reported to have a 
congenital cardiac defect compared to the other sites. Cooperation with oro-pharyngeal 
examination was achieved in 88% of participants. There were no differences between sites in 
percentage of children with tonsillar hypertrophy (Brodsky grade 3-4). Children that were not 
examined were significantly younger that those who were successfully examined (median age 
19 months versus 39 months (both range 6-71 months). The majority of children were within 
a healthy BMI range, as may be predicted with a young population, with 19% of those aged 2 
years and above classified as overweight or obese according to customised DS growth charts. 
3.3 Cardiorespiratory polygraphy 
Of the 202 consented children, one was excluded prior to PG as they commenced home 
oxygen and became ineligible, and one dropped out. Of the remaining 200 children, 194 
families (97%) agreed to a domiciliary PG study. Families of 6 children chose to have studies 
in the sleep laboratory. Figure 2 illustrates the locations of PG studies, including those that 
were repeated (due to < 4 hours of interpretable data) as well as the points at which children 
dropped out. Overall, 188 successful studies were achieved requiring an average of 1.3 
studies per successful data acquisition. Of the domiciliary PG studies, 74% were successful 
on first attempt compared to 95% of studies in the sleep laboratory. 
3.4 Inter-rater scoring reliability  
Blind inter-rater scoring was undertaken for 17 studies. A reliability coefficient of 0.917 
(95% CI 0.791 to 0.969) was achieved for the main outcome variable, OAHI, and 0.988 (95% 
CI 0.967, 0.995) for estimated total sleep time (i.e. total time analysed, TTA), indicating 
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excellent inter-rater scoring agreement. Taking an OAHI threshold of > 5/hr as a diagnostic 
criteria for moderate to severe OSA there was 100% agreement between the two scorers. 
 
3.5 Quality of studies  
Across the three centres children achieved on average just over 8 hours of TTA (mean 499.1, 
SD 101.6, range 261-673 minutes). Comparing the 19 studies achieved in the laboratory and 
the 169 achieved in the home setting,  TTA was greater in home studies compared to 
laboratory studies but this difference was not statistically significant (median home 514 
versus 468 minutes in laboratory, P =0.170). Similarly total time with flow in situ did not 
differ significantly between the two settings although was greater in the laboratory than at 
home (median home 212 versus 309 minutes in laboratory (P=0.835).  There was a weak 
positive correlation between age and TTA (r = .18, P=0.012), with older children achieving 
more minutes of artefact-free data, but not between age and total time achieved with flow in 
situ.  
3.6 Respiratory variables 
Table 2 illustrates the respiratory parameters derived from the scored cardiorespiratory PG 
studies. There were no differences by center, other than in total artefact free data analysed 
which was significantly higher in the Southampton and Sheffield centres compared to the 
London centre (median 537 mins and 498 respectively versus 469 mins; P=0.004). Figure 3 
illustrates distribution of OAHI values across the entire group. As can be seen, the majority 
of children, 73%, (95% CI 66%-79%), have an OAHI>1/hour, that indicates at least mild 
OSA. Given the lack of certainty about what constitutes a clinically significant OAHI in 
children with DS, the data are also presented according to different diagnostic thresholds 
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(table 3). Importantly, even taking a more conservative threshold of OAHI > 5/hour, we 
report prevalence rates of 14% (95% CI 10%, 20%).  
3.7 Factors predicting OSA  
Key potential predictors of moderate-severe OSA, as defined by an OAHI of > 5/hour, were 
examined (table 4). Age, parental socio-economic status, gestation at birth, exposure to 
cigarette smoke in the home, history of wheeze, rhinitis and congenital cardiac disease, 
overweight and obesity did not predict OSA. The prevalence of severe OSA was slightly 
higher (6; 21%) amongst the 29 children with previous tonsillectomy and/or adenoidectomy 
than amongst the 147 children without this history (19; 13%) but the difference was not 
statistically significant (P=0.274). In the unadjusted model male gender and clinical history 
of ‘always or almost always snoring in the absence of a cold’ predicted OSA but did not have 
independent predictive power in the presence of the other factors. 
Discussion 
This is the largest study reported to date describing the prevalence and predictors of OSA in a 
young, European population of children with DS.  We have reported OSA prevalence based 
on multiple diagnostic thresholds as a reference point for future research.  
Large population based studies in TD children have established that moderate to severe OSA 
(OAHI of > 5/hour) is associated with risk of systemic hypertension27 and a broad range of 
neuropsychological impairments28. Importantly, a recent European Respiratory Society task 
force29 concluded that an OAHI >5 per hour was a meaningful clinical treatment threshold in 
TD children aged 2-18 years, irrespective of symptomatology.  We report a prevalence rate of 
14% (95% confidence intervals 10-20%) of moderate to severe OSA in our sample, higher 
than the 0.2% prevalence reported in healthy TD 5-7 year olds27,  but lower than previous 
reports in children with DS. De Miguel-Diez and colleagues17, reported moderate to severe 
OSA in 45% of 108 children aged 1-18 years, while Austeng et al. reported a 66% prevalence 
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in 25 children aged 8 years21. A number of factors may explain the lower prevalence in our 
study group. Firstly our population was considerably younger than in previous studies, with a 
narrow age range. While de Miguel-Diez et al. reported a small but positive association 
between younger age (< 8 years) and OSA17, a large population-based study of 700 TD 
children reported lower prevalence rates of OSA in children aged 5-7 years (0.2%) compared 
to children aged 9-12 years (2.0%) 27. Maris et al22 reported OSA in 66.4% of 122 children 
with DS aged 0-18 years (based on a threshold of OAHI> 2/hour), this compares to 44% at 
this diagnostic threshold in our study. However, the two populations cannot be directly 
compared. In contrast to our data, 57% of Maris’s sample were clinically referred due to 
concerns about sleep disordered breathing. However, considering only the children over 4 
years of age, (who were routinely screened for OSA), a lower prevalence of OSA (53.8%) 
was reported, closer to our prevalence data of 44%.  
Finally, there may have been differences in the prevalence of overweight/obesity between our 
population and previous studies, although comparisons are constrained by the use of non-
standardised BMI data in previous reports rather than age and gender, DS specific BMI 
centiles used here.  
Future work is needed in a large sample of children with DS to establish the OSA severity 
thresholds associated with increased risk of neurocognitive and cardiovascular morbidity. We 
hypothesise that these children may be more vulnerable than TD children to the additional 
burden of OSA given their limited cognitive reserve and increased prevalence of congenital 
cardiac abnormalities. However, given the poverty of literature on OSA-associated morbidity 
in children with DS, and the increased risks associated with surgery30, few clinicians would 
recommend adenotonsillectomy at lower OAHI thresholds in the absence of clear OSA 
associated morbidity. We therefore focused our analysis of predictors of OSA using a 
diagnostic threshold of an OAHI >5/hour.  Unlike recent findings in a large community 
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sample of TD children27, our data suggested male gender to be a risk factor for OSA but 
predictive power was reduced after controlling for other variables. In line with the findings of 
de Miguel-Diez we did not demonstrate that body mass index centile (albeit using more 
specific DS growth charts), tonsillar grading or history of congenital cardiac abnormality 
predicted OSA. Data from a large cohort of TD children suggest that waist circumference, 
rather than BMI, may be a better predictor of OSA27 and this could usefully be assessed in 
future studies.  A history of regular snoring (always or almost always) was reported in almost 
one third of children, this compares to 3.6-7.7% of TD young children aged 6 months to 6.75 
years in a large UK population31 . On its own this factor was associated with over twofold 
increase in risk of OSA, but it did not have statistically significant independent predictive 
power in the presence of other factors. Previous researchers have reported clinical history and 
tonsillar grading to be poor predictors of OSA32,33.  Finally, we report for the first time in this 
population, that parental educational level, gestation at birth, exposure to cigarette smoke in 
the home and history of wheeze, and rhinitis are not major predictors of OSA.    
Study limitations 
It is important to recognise the limitations of the measurement technique chosen. The 
American Academy of Sleep Medicine34 recommends full polysomnography (PSG) for the 
investigation of childhood OSA, although recognises cardiorespiratory PG as a reliable 
alternative in adults.35  Like de Miguel-Diez and colleagues17, we chose to use domiciliary 
cardiorespiratory PG rather than laboratory PSG in this population. The choice was 
influenced by a number of factors; importantly, public consultation during protocol 
development indicated that parents were enthusiastic to trial home studies and many cited 
prior experience of their child sleeping poorly in a hospital setting. This was born out by the 
high uptake rate of domiciliary studies (94%) achieved in this study. In much of mainland 
Europe, full PSG is not available and the European Respiratory Society taskforce recognises 
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PG as an alternative diagnostic tool when PSG is not ‘fiscally or practically’ viable29. 
Cardiorespiratory PG can be used in the home setting where children, particularly those with 
learning disabilities, may sleep better than in hospital36. The principle limitation of PG is 
underestimation of the OAHI, as this technique cannot detect hypopneas associated with 
arousal rather than oxygen desaturation. Furthermore, in the absence of neurophysiological 
measures of sleep, interpretation of the sleep-wake state is constrained. The experienced 
scorers in this study achieved remarkable agreement in their scoring of total sleep time based 
on available signals and found the integrated actigraphy helpful in this respect. In support of 
this technology choice, recent data demonstrated that domiciliary PG predicted OSA (defined 
by OAHI ≥ 5.6/h on full PSG) with a sensitivity of 90.9% (95% CI, 79.6%-100%) and a 
specificity of 94.1% (95% CI, 80%-100%)37. Nonetheless it is possible that PG will have 
underestimated the OAHI in this population, particularly at lower diagnostic thresholds. We 
assessed the accuracy of cardiorespiratory PG compared to full PSG using the Somnotouch 
device with an added sleep module (standard EEG.EMG/EOG electrodes) in two children. 
The first was a 9 year old healthy volunteer studied at home and the second was a 7 year old 
inpatient with possible OSA. Neither study was attended. Two copies of the studies were 
made. The first was scored without sleep signals and the second scored with full 
polysomnography channels and sleep staging. OAHIs measured by PSG versus PG were not 
clinically significantly different (case 1: 0.2 v 0.1/hr; case 2: 6.6 v 6.1/hr respectively). Future 
evaluation of the accuracy of cardiorespiratory PG versus full PSG using this device in 
children with Down syndrome would be of value.  
A further limitation was the choice to not measure carbon dioxide overnight, so that we could 
not assess hypoventilation in these children. This was a pragmatic decision. Our aim was to 
assess obstructive events and we were concerned to streamline sensors to achieve optimal 
core signals.  
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Selection bias was limited through using multiple recruitment routes, the majority of children 
were recruited either from routine neurodevelopmental follow-up or through parent support 
networks. The fact that more children with congenital heart disease were recruited from the 
Southampton site, indicates a potential sampling bias in this centre. However, the presence of 
congenital heart disease was not one of the greatest predictors of OSA in our study, so it is 
unlikely this resulted in systematic bias in the prevalence of OSA reported. Furthermore our 
overall prevalence (69%) of parent reported congenital heart disease (which included 
temporary defects such as patent ductus arteriosus) was only slightly greater than estimates of 
population prevalence of up to 60% previously reported38.  
4. Conclusions and future work 
In summary, we report moderate to severe obstructive sleep apnea in 14% of a large cohort of 
188 young children with DS. This was not predicted by age, tonsillar size or body mass index 
standardised centile. On the basis of these findings we recommend that young children with 
DS are routinely screened for OSA in their pre-school years using objective measures, as 
clinical evaluation alone may be misleading. Further work is needed to identify the optimum 
method of screening, taking into account practical clinical challenges in children with 
intellectual disabilities. Our experience suggests that domiciliary cardiorespiratory studies are 
acceptable to many families. Importantly, fundamental knowledge needs to be built about the 
natural history, associated morbidity and optimum treatment approaches in this population, 
where OSA is likely to be associated with greater morbidity. The paucity of research in this 
field does not reflect a lack of health need, rather the invisibility of children with 
developmental disorders in mainstream pediatric research39. Children with DS are readily 
identifiable within health services and, from our experience, parents are enthusiastic for their 
child to participate in research. This research imbalance needs to be urgently and assertively 
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addressed. It cannot be assumed that OSA research in TD populations translates to children 
with DS who have different anatomical risk factors and cognitive profiles.   
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Figure 1: Recruitment  
  
277 children identified 
as potential participants  
202 consented  
(76% of eligible children) 
266 (96%) met inclusion 
criteria  
11 (4%) 
excluded   
64 declined 
(24% of eligible) 
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Figure 2: Setting for cardiorespiratory studies  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 legend: Flow of participants through cardiorespiratory studies illustrating success 
rates and numbers repeated in each setting. Numbers in red indicate where children dropped 
out of study having failed to achieve an adequate cardiorespiratory study, those in black 
indicate children who had repeat studies and those in green indicate successful studies. 
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Table 1: Demographic and clinical characteristics of participants from each centre. Figures are 
number (%) unless stated otherwise. 
  S’hampton London Sheffield All centres 
P value 
Maximum numbers available1 82 60 60 2021 
Male gender 40 (49%) 33 (55%) 36 (62%) 110 (55%) 0.3122 
Age in 
months 
mean (min to max) 38 (6 to 71) 35 (6 to 71) 35 (6 to 71) 36 (6 to 71) 0.5113 
Education of 
primary 
carer 
Degree or higher 33 (42%) 27 (45%) 21 (37%) 81 (42%) 0.0974 
HND7 or equivalent 21 (27%) 13 (22%) 3 (5%) 37 (19%)  
A-level 8 (10%) 5 (8%) 12 (21%) 25 (13%)  
GCSE8 A-C grade  1 9 (12%) 10 (17%) 11 (19%) 30 (15%)  
Lower grade GCSE or 
below 
7 5 10 22  
Gestation 
(WHO 
category) 
Term (37) 
Moderately preterm (32-36) 
Very preterm (28-31) 
Extremely preterm (<28) 
61 (74%) 47 (80%) 46 (78%) 154 (77%) 0.5014 
18 (22%) 11 (19%) 13 (22%) 42 (21%)  
1 1 0 2  
2 0 0 2  
Does the child always or almost always 
snore when they do not have a cold 
22 (28%) 24 (42%) 17 (29%) 63 (32%) 0.1702 
History of tonsillectomy and/or 
adenoidectomy 
14 (17%) 9 (15%) 10 (17%) 33 (16%) 0.9442 
History of rhinitis 24 (30%) 15 (26%) 7 (12%) 46 (23%) 0.0372 
History of wheeze  56 (69%) 24 (40%) 16 (27%) 96 (48%) 0.0002 
Use of prophylactic inhalers for wheeze 9 (11%) 11(18%) 7 (12%) 27 (13%) 0.4512 
Cigarette smoker in the home 14 (17%) 3 (5%) 4 (7%) 21 (10%) 0.0352 
Congenital cardiac defect 67 (82%) 35 (58%) 37 (62%) 139 (69%) 0.0042 
Brodsky 
grading5 
(% of those 
examined) 
 
Grade 0-2 (or tonsils 
removed) 
45 (76%) 36 (75%) 30 (60%) 111 (71%) 0.1306 
Grade 3-4 14 (24%) 12 (25%) 20 (40%) 46 (29%)  
 
Uncooperative (%total)  
 
23 ( 28%) 
 
12 (20%) 
 
10 (17%) 
 
45 (22%) 
 
BMI centile 
(restricted to those aged 
≥ 2 years, omitting 
uncooperative from %s) 
Underweight 2 (4%) 2 (5%) 1 (3%) 5 (4%) 0.4304 
Normal 
weight 
43(77%) 32 (82%) 25 (74%) 100 (78%)  
Overweight 3 (5%) 2 (5%) 2 (6%) 7 (5%)  
Obese 8 (14%) 3 (8%) 6 (18%) 17 (13%)  
Uncooperative 3 1 1 5  
Overweight/obese 
(restricted to those aged ≥ 2 years,  
11 (20%) 5 (13%) 8 (24%) 24 (19%) 0.4856 
1 7 missing values for education level and snoring; 3 missing values for rhinitis; 2 missing values for 
gestational age; 1 missing value for wheeze 
2 Chi-squared test for differences across centers 
3 ANOVA for differences.3 in means across centers 
4 Kruskal-Wallis test for differences across centers 
5 Grade 0-2 occupy 0-50%, and grade 3-4 occupy 50-100% of the space between the tonsillar pillars 
6 Percentages and chi-squared test for difference across centers excluding uncooperative children 
7 HND (Higher National Diploma) UK qualification used for university entrance at advanced level, in 
some circumstance considered equivalent to the second year of a three-year university degree course. 
8 GCSE (General Certificate of Secondary Education) state examination for children aged 16 years. 
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Table 2: Distribution of Apnea/Hypopnea indices 
Successful studies number = 188  Median  
 
IQR 
 
Min to max 
Artefact-free analysis time (mins) 506name 
 
423.5 to 584.8 
 
261 to 673 
Mean oxyhemoglobin saturation % 98 
 
97 to 99 
 
88 to 100 
Min oxyhemoglobin saturation % 88.0 
 
83 to 90 
 
39 to 97 
3% oxygen desaturation index 12.4 
 
7.2 to 22.0 
 
0.2 to 106.6 
Obstructive apnea index 0.2 
 
0.0 to 0.9 
 
0.0 to 48.3 
Obstructive hypopnea index 0.2 
 
0.0 to 1.0 
 
0.0 to 14.5 
Central apnea index 1.7 
 
0.9 to 3.1 
 
0.0 to 14.7 
Mixed apnea index 0.0 
 
0.0 to 0.1 
 
0 to 1.8 
Undefined apnea index  0.6 
 
0.1 to 1.4 
 
0.0 to 57.3 
Obstructive apnea/hypopnea index 1.7 
 
0.9 to 3.2 
 
0.0 to 110.4 
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Table 3: Prevalence of OSA based on suggested OAHI thresholds  
Diagnostic OAHI threshold n Prevalence (95% CI) 
>/=10/hour 15/188 8% (5%, 13%) 
>/= 5/hour 27/188 14% (10%, 20%) 
>/= 2/hour 82/188 44% (37%, 51%) 
>/= 1.5/hour 110/188 59% (51%, 65%) 
>/= 1/hour 138/188 73% (67%, 79%) 
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Table 4: Predictors of OAHI >5/hour 
  Unadjusted (n=1761) Adjusted2 (n=176) 
  Odds ratio2 
(95% CI) 
P Odds ratio4 
(95% CI) 
P 
Male (vs female) gender 2.68 (1.06, 6.78) 0.030 2.55 (0.96, 6.79) 0.053 
Age per unit increase in months 0.99 (0.97, 1.01) 0.482 0.98 (0.96, 1.01) 0.200 
Parents’ educational level per one 
category increase 
0.87 (0.66, 1.13) 0.290 0.90 (0.66, 1.22) 0.503 
Gestational per unit increase in weeks 1.06 (0.88, 1.27) 0.552 1.03 ((0.84, 1.27) 0.754 
Cigarette smoker in the home 
0.31 (0.04, 2.42) 0.188 0.22 (0.03, 1.87) 0.100 
History of tonsillectomy and/or 
adenoidectomy 
1.76 (0.63, 4.87) 0.294 2.48 (0.74, 8.35) 0.149 
History of rhinitis 
1.29 (0.50, 3.34) 0.606 0.99 (0.33, 2.99) 0.984 
History of wheeze  
2.00 (0.83, 4.82) 0.114 1.85 (0.71, 4.81) 0.204 
Congenital cardiac defect 
0.78 (0.32, 1.89) 0.584 0.82 (0.31, 2.17) 0.697 
Child always or almost always snore 
when they do not have a cold 
2.40 (1.02, 5.65) 0.046 1.97 (0.73, 5.35) 0.183 
Brodsky grade per unit increase in 
grade (n=140) 
0.95 (0.61, 1.48) 0.818 0.53 (0.27, 1.04) 0.054 
Overweight/obese restricted to those 
aged ≥ 2 years (n=114) 
0.69 (0.14, 3.34) 0.635 0.72 (0.10, 5.16) 0.645 
1 176 children with complete information on OAHI and the predictors listed2 
2 Adjusted for gender, age, educational level, gestational age, smoking, history of 
tonsillectomy/adenoidectomy, rhinitis, wheeze, cardiac defect, snoring without a cold 
3Odds ratios less than 1 indicate that the predictor reduces the odds of OAHI≥5/hour. Odds ratios 
greater than 1 indicate that the predictor increases the odds of OAHI≥5/hour 
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Figure 2: Distribution of the OAHI showing potential diagnostic thresholds6 
 
 
                                                          
6 Note individual with OAHI = 0 has been included by replacing their value with the minimum 0.06 
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